Abstracts tagged "Cutaneous manifestations and polyarteritis nodosa"

Abstract Number: 2477 • 2012 ACR/ARHP Annual Meeting
The Comparison of Childhood Polyarteritis Nodosa and Cutaneous Polyarteritis Nodosa and a New Set of Diagnostic Criteria for Cut-Polyarteritis Nodosa
Erkan Demirkaya¹, Seza Ozen¹, Turker Turker¹, Rubén J. Cuttica², Paul Brogan¹, Pierre Quartier¹, Jordi Anton³, Nuray Aktay Ayaz⁴, Stella Maris Garay⁵, Graciela Espada¹, Raju Khubchandani⁶, Francesco Zulian¹, Arvind Bagga¹, Alexandre Belot¹, Clovis Artur Silva¹, Sulaiman Al-Mayouf¹, Amparo Ibanez Estrella¹, Sheila Oliveira⁷, Cengizhan Acikel¹, Claudia Saad-Magalhães¹, Alberto Martini⁸ and Nicolino Ruperto¹, ¹Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy, ²Hospital de Niños Pedro de Elizalde - University of Buenos Aires, Buenes Aires, Argentina, ³Rheumatology, Hospital Sant Joan de Deu, Barcelona, Spain, ⁴Bakırkoy Maternity and Childrens Education and Research Hospital, Istanbul, Turkey, ⁵PRINTO, Genoa, Italy, ⁶Rheumatology, Jaslok Hospital and Research Center, Mumbai, India, ⁷Istituto Giannina Gaslini, Pediatria II, Reumatologia, Paediatric Rheumatology International Trials Organisation (PRINTO) Coordinating Center, Genoa, Italy, Genova, Italy, ⁸Pediatric Rheumatology Collaborative Study Group [PRSCG], Cincinnati, OH
AbstractBackground/Purpose: Systemic polyarteritis nodosa (PAN) is a predominantly medium size vasculitis characterized by non granulomatous necrotizing vasculitis. We aimed to evaluate clinical, laboratory and imaging…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].